Large global market due to the significant number of cancer cases linked to infections. Feasible to develop an MVP using existing AI/ML models for data analysis and risk assessment, though data integration can be complex. The market has some research tools but lacks a dedicated, accessible SaaS for personalized tracking and public health insights. Easily localizable due to the universal nature of cancer and infections, with varying data availability per region.